Biopharmadive.com - SEO Checker

Visión general del análisis SEO
Metadatos
80% 
Calidad de la página
83% 
Estructura
29% 
Enlazado
51% 
Servidor
78% 
Factores externos
100% 
Puntuación SEO
Tiempo de carga
0,87 s
Tamaño HTML
287,90 kB
Palabras
1855
Medios
111
Cantidad de enlaces
138 internos / 28 externos

Lista de tareas pendientes para mejorar tu SEO

Metadatos

Título
(Extremadamente importante)
Biotech and Pharma Industry News | BioPharma Dive
La longitud del título es óptima (477 píxeles de una longitud máxima de 580 píxeles).
No se repite ninguna palabra en el título.
Meta descripción
(Extremadamente importante)
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
La meta descripción es demasiado larga: 1000 píxelesOptimizar la descripción.
Rastreabilidad
(Extremadamente importante)
No se detectan problemas para acceder al sitio web.
Redirección canónica
(Importante)
No se especifica ningún enlace canónico.
Idioma
(Poco importante)
Idioma reconocido automáticamente en el contenido: en
Idioma declarado en el código HTML: en-us
Ubicación geográfica del servidor: Canadá
El idioma ha sido correctamente declarado en el código HTML: en-us.
Enlaces Alternate/Hreflang
(Poco importante)
No se ha encontrado ningún enlace alternativo (alternate) en esta página.
Otras Metaetiquetas
(Poco importante)
No se detecta ninguna metaetiqueta de paginación rel next en la página.
No se detecta ninguna metaetiqueta de paginación rel prev en la página.
Dominio
(Poco importante)
El dominio no es un subdominio.
La longitud del nombre del dominio es buena.
El dominio no contiene caracteres especiales.
URL de la página
(Poco importante)
No se detecta ningún parámetro dinámico en la URL.
No se detecta ningún ID de sesión en la URL.
La URL no contiene demasiados subdirectorios.
Codificación de caracteres
(Poco importante)
La codificación de caracteres (UTF-8) ha sido declarada correctamente.
Doctype
(Deseable)
La etiqueta doctype HTML 5 está configurada correctamente.
La declaración del doctype se ubica al inicio del código HTML.
Favicon
(Deseable)
El favicon está enlazado correctamente.

Metaetiquetas

NombreValor
viewportwidth=device-width, initial-scale=1.0
descriptionBioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
msapplication-TileImage/mstile-150x150.png?v=3
msapplication-TileColor#603cba
theme-color#ffffff
langen-us
fb:pages398644486955359
og:titleBiotech and Pharma Industry News | BioPharma Dive
og:descriptionBioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.
og:imagehttps://d12v9rtnomnebu.cloudfront.net/divesite/header_image_logos/biopharma_dive_feed_header.jpg
x-ua-compatibleie=edge
charsetutf-8

¡Analiza ya hasta 25.000 páginas de biopharmadive.com!

Probar gratis
Garantizada la gratuidad durante la fase de prueba.

Calidad de la página

Contenido
(Extremadamente importante)
Algunas palabras del encabezado H1 no se repiten en el cuerpo del texto.
El número total de palabras en la página es bueno: 1855 palabras.
Un 27.4% del contenido está constituido por palabras vacías.
Las palabras clave del título también se repiten en el texto del cuerpo.
La página contiene un listado, lo que indica una buena estructuración del contenido.
Se han encontrado 29 párrafos en esta página.
No se detecta ningún placeholder de texto ni imagen.
No se detecta contenido duplicado.
La cantidad media de palabras por frase es buena: 16.7 palabras.
Frames
(Extremadamente importante)
Esta página no utiliza ningún frameset.
Optimización para móviles
(Poco importante)
El valor de la etiqueta viewport es correcto: (width=device-width, initial-scale=1.0).
Al menos un icono de Apple-Touch ha sido especificado.
Etiquetas Bold y Strong
(Poco importante)
El uso de etiquetas de negritas en esta página es óptimo. Te recomendamos emplear hasta 37 etiquetas de negritas en una página.
Optimización de imágenes
(Poco importante)
No se detecta ninguna descripción del atributo ALT en 5 imágenes. El contenido de los atributos ALT también es evaluado como texto por los buscadores y es muy importante para la búsqueda de imágenes.
Redes Sociales
(Deseable)
Esta página apenas ofrece posibilidades de compartir el contenido en redes sociales. Con la integración de widgets puedes conseguir que tus contenidos se popularicen en redes.
Etiquetas markup adicionales
(Deseable)
No se detecta ninguna etiqueta markup (de Schema.org) adicional.
HTTPS
(Poco importante)
El sitio utiliza HTTPS para transferir datos de forma segura.
Todos los archivos incluidos se transfieren a través de HTTPS.

Lista de medios

URLAtributo ALTTítulo
...et/logo/publications/biopharma_black.svgBioPharma Dive
...et/logo/publications/biopharma_black.svgBioPharma Dive
...tic/img/menu_icons/menu.svg?273117231121menu
...c/img/menu_icons/search.svg?320116291121search
...ic/img/email_icons/mail.svg?273117231121Carece de atributo ALT
...c/img/menu_icons/search.svg?320116291121search
...ic/img/menu_icons/close.svg?273117231121close search
...WdlL2RpdmVpbWFnZS9lbmhlcnR1LmpwZw==.webpEnhertu
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...WFnZS9NQV9oZWFkZXJfZVVpQk81cy5wbmc=.webpAn illustration for BioPharma Dive's deals database
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...W1hZ2VfMTA0MHg2MTZfa2NZMmh5Zy5wbmc=.webpA Young woman standing on the platform of a train station
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...WdlL2RpdmVpbWFnZS9OQTJfMTQ1Ni5qcGc=.webpPhysicians, researchers and healthcare professionals attend ASCO's annual Meeting on June 2, 2023 in Chicago.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMDI1ODM3NzM4LmpwZw==.webpA large group of dosing pens for subcutaneous injection of anti-obesity medication piled in a heap.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xNDgzOTIxNzkzLmpwZw==.webpA stack of newspapers are seen against a blue background.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xMjI3NzEwNDk4LmpwZw==.webpCarece de atributo ALT
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMjAyMTI1MjYzLmpwZw==.webpA person in a blue suit gestures while seated at a conference table.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xNzMyMDUyNTc5LmpwZw==.webpSpermatozoon is injected into an ovum with help of microneedle and holding pipette underneath a microscope
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xMjg4NjcwMjY5LmpwZw==.webpThe Moderna headquarters is seen on November 30, 2020 in Cambridge, Massachusetts.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMjA5Nzg3ODAxLmpwZw==.webpA sign spelling Roche hangs on the side of a building.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMjAzNjI4MTU5XzIuanBn.webpFDA administrator nominee Martin Makary speaks at a Senate confirmation hearing
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...W90ZWNoLWlwb3RyYWNrZXJoZWFkZXIucG5n.webpA stylized illustration of test tubes in front of a red line on a chart going up and to the right.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xNDgzOTIxNzkzLmpwZw==.webpA stack of newspapers are seen against a blue background.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...WFnZS9QZml6ZXJfSFFfRW50cmFuY2UuanBn.webpPfizer HQ entrance
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xOTc4MjM1MzE3LmpwZw==.webp23andMe
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...F9Hb3R0ZXNkaWVuZXJfakplSWV6Sy5qcGc=.webpA person in a white shirt sits in an office for a photograph.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...WFnZS9wYXRlbnRfdGhpY2tldF80LnBuZw==.webpA stylized illustration of a "patent thicket" for Jonathan Gardner's Nov. 1 story on Amgen's Enbrel.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...2RpdmVpbWFnZS9GREFfSFFfR2V0dHkuanBn.webpThe headquarters of the FDA, which has recently issued a recall for Teleflex air filters used in hospital respirators.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xMjM4ODMwMjMyLmpwZw==.webpA worker prepares ampoules of the Nuvaxovid vaccine against Covid-19 by Novavax in Berlin, Germany in February 2022.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xNDgzOTIxNzkzLmpwZw==.webpA stack of newspapers are seen against a blue background.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMTc0MjA0OTkxLmpwZw==.webpA person in a suit sits at a desk with a microphone.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0xMjg5Nzg0NjQwLmpwZw==.webpA white office building bearing a sign for BioMarin Pharmaceutical stands against a blue sky.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...Wdlcy0xMjI3NzEwNDk4X3pJUnRuUlcuanBn.webpFDA
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...TY5MDc4MzcxMl8yYTc1ZmQ5M2MyX28uanBn.webpA photo of Sanofi headquarters in Paris, France.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...mJWaWVfVVNfSGVhZHF1YXJ0ZXJzLmpwZw==.webpAn AbbVie sign is seen on a building at the pharmaceutical company's U.S. headquarters.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...XR0eUltYWdlcy0yMTk5NDI3NjE2LmpwZw==.webpSen. Chuck Grassley gestures as he speaks during a committee meeting.
/static/images/info-icon.png?234917240220Image attribution tooltip
/static/images/info-icon.png?234917240220Image attribution tooltip
...nts/buttons/right-arrow.svg?353714160519next icon
...XR0eUltYWdlcy0xOTc4MjM1MzE3LmpwZw==.webp23andMe
...XR0eUltYWdlcy0yMjAzNjI4MTU5XzIuanBn.webpFDA administrator nominee Martin Makary speaks at a Senate confirmation hearing
...F9Hb3R0ZXNkaWVuZXJfakplSWV6Sy5qcGc=.webpA person in a white shirt sits in an office for a photograph.
...2RpdmVpbWFnZS9GREFfSFFfR2V0dHkuanBn.webpThe headquarters of the FDA, which has recently issued a recall for Teleflex air filters used in hospital respirators.
...lib_icons/webinar-black.svg?141716111021studioID resource icon
...ib_icons/playbook-black.svg?141716111021studioID resource icon
...ib_icons/playbook-black.svg?141716111021studioID resource icon
...ars-focus-rare-disease-grows-2025-05-22/Carece de atributo ALT
/static/img/offsite.svg?141716111021offsite link
...y/rfk-jr-maha-commission-report-5c13696dCarece de atributo ALT
/static/img/offsite.svg?141716111021offsite link
...-trump-medicaid-coverage-south-carolina/Carece de atributo ALT
/static/img/offsite.svg?141716111021offsite link
/static/img/signup-dive.png?080016020822Daily Dive newsletter example
...oudfront.net/logo/corporate/ID_black.svgIndustry Dive Logo
...s/article_page/linkedin.svg?092716141024linkedin icon
...s/article_page/facebook.svg?440116200824facebook icon
...al_icons/article_page/x.svg?092716141024x icon
..._icons/article_page/rss.svg?440116200824rss feed icon
...ic/img/menu_icons/close.svg?273117231121close menu
...c/img/menu_icons/search.svg?320116291121search
...menu_icons/chevron_down.svg?410116200325down arrow

Estructura de la página

Encabezado H1
(Extremadamente importante)
Don't miss tomorrow's biopharma industry news
Más de un encabezado H1.
Encabezados
(Importante)
Hay 47 encabezados H en esta página. La cantidad de encabezados debería guardar una mejor proporción en relación al texto.

Estructura de los encabezados

Jerarquía de encabezadosContenido
H1 Don't miss tomorrow's biopharma industry news
H1 AI tool could help doctors ID breast cancers vulnerable to Enhertu
H2 Top stories
H2 The Latest
H3 FDA panel recommends keeping COVID shots targeted to same strain as last year
H3 Sanofi gains experimental Alzheimer’s drug through Vigil buyout
H3 A bespoke CRISPR therapy suggests a blueprint for treating ‘N-of-1’ diseases
H3 Women’s health faces growing headwinds, despite jump in venture investment
H3 Facing ‘uncertainty on steroids,’ biotech dealmakers tread more cautiously
H3 Biotech’s M&A outlook is uncertain. Track the deals that are happening here.
H3 From insight to impact: How eCOAs strengthen trial data quality
H3 Zepzelca, Tecentriq combo extends survival in hard-to-treat lung cancer
H3 Novo pressures GLP-1 compounders as FDA ban takes hold
H3 FDA advisers pan Pfizer’s PARP drug; Sarepta to resume Duchenne study
H3 FDA panel backs Darzalex for early stage multiple myeloma
H3 The Trump administration is remaking HHS. Track the changes here.
H3 Reproductive health startup raises $65M for infertility drugs
H3 Moderna pulls application for combo COVID, flu shot
H3 Roche strikes second Orionis deal to develop ‘molecular glues’ for cancer
H3 FDA sets stricter approval standards for COVID vaccines
H3 Biotech startups are built on venture capital. Track funding rounds here.
H3 Tourmaline shares fall on Phase 2 data; Schrödinger cuts staff
H3 Pfizer buys into PD-1/VEGF competition with 3SBio deal
H3 Regeneron wins bid to buy 23andMe out of bankruptcy
H3 Prime Medicine claims ‘proof of concept,’ but lays off staff in pivot
H3 Drug patents protect pharma profits. Track when they’ll expire.
H3 FDA OKs first blood test to aid Alzheimer’s diagnosis
H3 Novavax’s COVID vaccine gets FDA approval, but with limits
H3 Regeneron defeats Amgen in PCSK9 case; 2 cell therapy biotechs cut staff
H3 Novo CEO to depart as obesity drugmaker’s challenges rise
H3 BioMarin to buy rare disease drugmaker Inozyme for $270M
H3 FDA delays approval decision for Biohaven rare disease drug
H3 Sanofi to pour more than $20B into US drug research and manufacturing
H3 AbbVie stakes $335M on a startup’s RNAi drugs
H3 Stopping a ‘moral obscenity’: Senate Judiciary Committee expresses support for PBM reform
H3 Get the free newsletter
H3 Most Popular
H3 Library resources
H3 Company Announcements
H3 What We're Reading
H3 Events
H3 Industry Intel
H3 BioPharma Dive news delivered to your inbox
H3 Get BioPharma Dive in your inbox
H4 Explore
H4 Reach our audience
H4 Related Publications
Algunos enlaces internos contienen parámetros dinámicos. Las URL internas no deberían contener parámetros dinámicos, salvo que estén marcadas como nofollow.
Algunos textos ancla se repiten más de una vez en varios enlaces.
1 enlaces cerecen de un texto ancla.
La cantidad de enlaces internos es adecuada.
Ningún texto ancla es excesivamente largo.
Hay demasiados enlaces externos (28) en esta página.
EnlacePropiedadesTexto ancla
https://www.biopharmadive.com/Texto ancla Skip to main content
https://www.techtarget.com/ter...Nueva ventana Externo Subdominio Terms of Use
https://www.techtarget.com/pri...Nueva ventana Externo Subdominio Privacy Policy
https://www.biopharmadive.com/IMG-ALT BioPharma Dive
/deep-dive/Deep Dive
/library/Library
/events/Events
/press-release/Press Releases
/signup/?signup_location=headerNofollow Sign up
/signup/?signup_location=headerNofollow Texto duplicado Sign up
/topic/pharma/Pharma
/topic/biotech/Biotech
/topic/fda/FDA
/topic/clinical-trials/Clinical Trials
/topic/deals/Deals
/topic/drug-pricing/Drug Pricing
/topic/gene-therapy/Gene Therapy
/news/her2-breast-cancer-diagn...IMG-ALT Enhertu
/news/her2-breast-cancer-diagn...AI tool could help doctors ID breast cancers vulnerable to Enhertu
/news/her2-breast-cancer-diagn...Read more ➔
/news/fda-covid-vaccine-advise...FDA panel recommends keeping COVID shots targeted to same strain as last year
/news/sanofi-vigil-acquisition...Sanofi gains experimental Alzheimer’s drug through Vigil buyout
/news/crispr-n-of-1-gene-editi...A bespoke CRISPR therapy suggests a blueprint for treating ‘N-of-1’ diseases
/news/womens-health-venture-fu...Women’s health faces growing headwinds, despite jump in venture investment
/news/deals-pharma-biotech-mar...Facing ‘uncertainty on steroids,’ biotech dealmakers tread more cautiously
/news/biotech-pharma-deals-mer...IMG-ALT An illustration for BioPharma Dive's deals database
/news/biotech-pharma-deals-mer...Biotech’s M&A outlook is uncertain. Track the deals that are happening here.
/topic/deals/Texto duplicado Deals
/spons/from-insight-to-impact-...IMG-ALT A Young woman standing on the platform of a train station
/spons/from-insight-to-impact-...From insight to impact: How eCOAs strengthen trial data quality
/topic/clinical-trials/Texto duplicado Clinical Trials
/news/zepzelca-tecentriq-small...IMG-ALT Physicians, researchers and healthcare professionals attend ASCO's annual Meeting on June 2, 2023 in Chicago.
/news/zepzelca-tecentriq-small...Zepzelca, Tecentriq combo extends survival in hard-to-treat lung cancer
/topic/pharma/Texto duplicado Pharma
/news/novo-access-wegovy-glp-1...IMG-ALT A large group of dosing pens for subcutaneous injection of anti-obesity medication piled in a heap.
/news/novo-access-wegovy-glp-1...Novo pressures GLP-1 compounders as FDA ban takes hold
/topic/manufacturing/Manufacturing
/news/pfizer-talzenna-prostate...IMG-ALT A stack of newspapers are seen against a blue background.
/news/pfizer-talzenna-prostate...FDA advisers pan Pfizer’s PARP drug; Sarepta to resume Duchenne study
/topic/pharma/Texto duplicado Pharma
/news/fda-panel-backs-darzalex...Sin texto
/news/fda-panel-backs-darzalex...FDA panel backs Darzalex for early stage multiple myeloma
/topic/pharma/Texto duplicado Pharma
/news/hhs-fda-restructuring-la...IMG-ALT A person in a blue suit gestures while seated at a conference table.
/news/hhs-fda-restructuring-la...The Trump administration is remaking HHS. Track the changes here.
/topic/pharma/Texto duplicado Pharma
/news/repronovo-series-a-ferti...IMG-ALT Spermatozoon is injected into an ovum with help of microneedle and holding pipette underneath a microscope
/news/repronovo-series-a-ferti...Reproductive health startup raises $65M for infertility drugs
/topic/biotech/Texto duplicado Biotech
/news/moderna-withdraw-fda-cov...IMG-ALT The Moderna headquarters is seen on November 30, 2020 in Cambridge, Massachusetts.
/news/moderna-withdraw-fda-cov...Moderna pulls application for combo COVID, flu shot
/topic/biotech/Texto duplicado Biotech
/news/roche-orionis-molecular-...IMG-ALT A sign spelling Roche hangs on the side of a building.
/news/roche-orionis-molecular-...Roche strikes second Orionis deal to develop ‘molecular glues’ for cancer
/topic/biotech/Texto duplicado Biotech
/news/fda-covid-booster-approv...IMG-ALT FDA administrator nominee Martin Makary speaks at a Senate confirmation hearing
/news/fda-covid-booster-approv...FDA sets stricter approval standards for COVID vaccines
/topic/fda/Texto duplicado FDA
/news/biotech-venture-capital-...IMG-ALT A stylized illustration of test tubes in front of a red line on a chart going up and to the right.
/news/biotech-venture-capital-...Biotech startups are built on venture capital. Track funding rounds here.
/topic/biotech/Texto duplicado Biotech
/news/tourmaline-pacibekitug-s...Texto duplicado IMG-ALT A stack of newspapers are seen against a blue background.
/news/tourmaline-pacibekitug-s...Tourmaline shares fall on Phase 2 data; Schrödinger cuts staff
/topic/pharma/Texto duplicado Pharma
/news/pfizer-3sbio-pd1-vegf-ca...IMG-ALT Pfizer HQ entrance
/news/pfizer-3sbio-pd1-vegf-ca...Pfizer buys into PD-1/VEGF competition with 3SBio deal
/topic/pharma/Texto duplicado Pharma
/news/regeneron-23andme-acquir...IMG-ALT 23andMe
/news/regeneron-23andme-acquir...Regeneron wins bid to buy 23andMe out of bankruptcy
/topic/biotech/Texto duplicado Biotech
/news/prime-medicine-restructu...IMG-ALT A person in a white shirt sits in an office for a photograph.
/news/prime-medicine-restructu...Prime Medicine claims ‘proof of concept,’ but lays off staff in pivot
/topic/biotech/Texto duplicado Biotech
/news/patent-cliff-pharmaceuti...IMG-ALT A stylized illustration of a "patent thicket" for Jonathan Gardner's Nov. 1 story on Amgen's Enbrel.
/news/patent-cliff-pharmaceuti...Drug patents protect pharma profits. Track when they’ll expire.
/topic/pharma/Texto duplicado Pharma
/news/fda-blood-test-alzheimer...IMG-ALT The headquarters of the FDA, which has recently issued a recall for Teleflex air filters used in hospital respirators.
/news/fda-blood-test-alzheimer...FDA OKs first blood test to aid Alzheimer’s diagnosis
/topic/marketing/Marketing
/news/novavax-covid-vaccine-fd...IMG-ALT A worker prepares ampoules of the Nuvaxovid vaccine against Covid-19 by Novavax in Berlin, Germany in February 2022.
/news/novavax-covid-vaccine-fd...Novavax’s COVID vaccine gets FDA approval, but with limits
/topic/biotech/Texto duplicado Biotech
/news/regeneron-amgen-pcsk9-tr...Texto duplicado IMG-ALT A stack of newspapers are seen against a blue background.
/news/regeneron-amgen-pcsk9-tr...Regeneron defeats Amgen in PCSK9 case; 2 cell therapy biotechs cut staff
/topic/pharma/Texto duplicado Pharma
/news/novo-nordisk-ceo-step-do...IMG-ALT A person in a suit sits at a desk with a microphone.
/news/novo-nordisk-ceo-step-do...Novo CEO to depart as obesity drugmaker’s challenges rise
/topic/pharma/Texto duplicado Pharma
/news/biomarin-inozyme-acquisi...IMG-ALT A white office building bearing a sign for BioMarin Pharmaceutical stands against a blue sky.
/news/biomarin-inozyme-acquisi...BioMarin to buy rare disease drugmaker Inozyme for $270M
/topic/deals/Texto duplicado Deals
/news/biohaven-fda-drug-approv...Texto duplicado IMG-ALT FDA
/news/biohaven-fda-drug-approv...FDA delays approval decision for Biohaven rare disease drug
/topic/biotech/Texto duplicado Biotech
/news/sanofi-11-billion-us-dru...IMG-ALT A photo of Sanofi headquarters in Paris, France.
/news/sanofi-11-billion-us-dru...Sanofi to pour more than $20B into US drug research and manufacturing
/topic/manufacturing/Texto duplicado Manufacturing
/news/abbvie-adarx-rna-interfe...IMG-ALT An AbbVie sign is seen on a building at the pharmaceutical company's U.S. headquarters.
/news/abbvie-adarx-rna-interfe...AbbVie stakes $335M on a startup’s RNAi drugs
/topic/biotech/Texto duplicado Biotech
/news/senate-judiciary-backs-p...IMG-ALT Sen. Chuck Grassley gestures as he speaks during a committee meeting.
/news/senate-judiciary-backs-p...Stopping a ‘moral obscenity’: Senate Judiciary Committee expresses support for PBM reform
/topic/pharma/Texto duplicado Pharma
/?page=2More stories
IMG-ALT next icon
https://www.techtarget.com/ter...Nueva ventana Externo Subdominio Texto duplicado Terms of Use
https://www.techtarget.com/pri...Nueva ventana Externo Subdominio Texto duplicado Privacy Policy
/news/regeneron-23andme-acquir...Texto duplicado IMG-ALT 23andMe
/news/regeneron-23andme-acquir...Texto duplicado Regeneron wins bid to buy 23andMe out of bankruptcy
/news/fda-covid-booster-approv...Texto duplicado IMG-ALT FDA administrator nominee Martin Makary speaks at a Senate confirmation hearing
/news/fda-covid-booster-approv...Texto duplicado FDA sets stricter approval standards for COVID vaccines
/news/prime-medicine-restructu...Texto duplicado IMG-ALT A person in a white shirt sits in an office for a photograph.
/news/prime-medicine-restructu...Texto duplicado Prime Medicine claims ‘proof of concept,’ but lays off staff in pivot
/news/fda-blood-test-alzheimer...Texto duplicado IMG-ALT The headquarters of the FDA, which has recently issued a recall for Teleflex air filters used in hospital respirators.
/news/fda-blood-test-alzheimer...Texto duplicado FDA OKs first blood test to aid Alzheimer’s diagnosis
http://resources.industrydive....Nueva ventana Externo Subdominio Scaling Smarter: How a Modern Tech Stack Fuels Diagnostic Lab Growth
https://biopharmadive.tradepub...Nueva ventana Externo Subdominio Supporting Patient Safety Through Supply Chain Management
https://biopharmadive.tradepub...Nueva ventana Externo Subdominio How Each Step in a Clinical Trial Fuels the Next
/library/View all
/press-release/Texto duplicado View all
/press-release/get-started/Post a press release
https://www.reuters.com/busine...Nueva ventana Externo Subdominio Prices for new US drugs doubled in 4 years as focus on rare disease grows
IMG-ALT offsite link
https://www.wsj.com/politics/p...Nueva ventana Externo Subdominio What’s Inside RFK Jr.’s MAHA Report
IMG-ALT offsite link
https://kffhealthnews.org/news...Nueva ventana Externo Trump Won’t Force Medicaid to Cover GLP-1s for Obesity. A Few States Are Doing It Anyway.
IMG-ALT offsite link
/what-we-are-readingTexto duplicado View all
https://events.industrydive.co...Nueva ventana Externo Subdominio State of Oncology Research
/selfservice/event-listings/co...Promote an event
http://resources.industrydive....Nueva ventana Externo Subdominio Evolving Regulatory Landscape for Model Informed Drug Development (MIDD): Impact of the Draft ICH M15 Guidance
http://resources.industrydive....Nueva ventana Externo Subdominio Unlock the Potential of Life Sciences and Health Systems Partnerships
https://resources.industrydive...Nueva ventana Externo Subdominio Top Ways that AI Will Change Life Sciences
https://www.techtarget.com/ter...Nueva ventana Externo Subdominio Texto duplicado Terms of Use
https://www.techtarget.com/pri...Nueva ventana Externo Subdominio Texto duplicado Privacy Policy
https://www.industrydive.com/Externo Subdominio IMG-ALT Industry Dive Logo
https://www.linkedin.com/compa...Externo Subdominio IMG-ALT linkedin icon
https://www.facebook.com/bioph...Externo Subdominio IMG-ALT facebook icon
https://twitter.com/BioPharmaDiveExterno IMG-ALT x icon
/feeds/news/Subdominio IMG-ALT rss feed icon
/about/About
/editors/Editorial Team
/contact/Contact Us
/signup/?signup_location=foote...Nofollow Newsletter
/selfservice/article-licensing...Nofollow Purchase Licensing Rights
/press-release/Texto duplicado Press Releases
/what-we-are-reading/What We're Reading
/advertise/Advertising
/press-release/get-started/Texto duplicado Post a press release
/selfservice/event-listings/co...Texto duplicado Promote an event
https://www.healthcaredive.com/Externo Subdominio Healthcare Dive
https://www.medtechdive.com/Externo Subdominio MedTech Dive
https://www.industrydive.com/i...Externo Subdominio other publications
https://www.techtarget.com/pri...Externo Subdominio Privacy policy
https://www.techtarget.com/ter...Externo Subdominio Terms of use
https://www.industrydive.com/t...Externo Subdominio Take down policy
https://www.biopharmadive.com/Home
/topic/pharma/Texto duplicado Pharma
/topic/biotech/Texto duplicado Biotech
/topic/fda/Texto duplicado FDA
/topic/clinical-trials/Texto duplicado Clinical Trials
/topic/deals/Texto duplicado Deals
/topic/drug-pricing/Texto duplicado Drug Pricing
/topic/gene-therapy/Texto duplicado Gene Therapy
/deep-dive/Texto duplicado Deep Dive
/library/Texto duplicado Library
/events/Texto duplicado Events
/press-release/Texto duplicado Press Releases
https://www.techtarget.com/ter...Nueva ventana Externo Subdominio Texto duplicado Terms of Use
https://www.techtarget.com/pri...Nueva ventana Externo Subdominio Texto duplicado Privacy Policy

Configuración del servidor

Redirecciones HTTP
(Extremadamente importante)
Esta página redirige a "https://www.biopharmadive.com/".
Cabecera HTTP
(Importante)
La cabecera X-Powered-by no se envía en la cabecera de la página.
El servidor web transmite la página web (HTML) comprimida.
Rendimiento
(Poco importante)
Con 0,87 segundos, el tiempo de respuesta de la página es superior al límite recomendado de 0,4 segundos. Un tiempo de respuesta elevado ralentiza innecesariamente el rastreo de los buscadores y propicia una mala experiencia de uso.
El tamaño HTML de la página es adecuado: 288 kB.

Cabecera HTTP

NombreValor
dateSun, 25 May 2025 09:24:08 GMT
content-typetext/html; charset=utf-8
sniply-optionsBLOCK
expiresSun, 25 May 2025 09:25:56 GMT
cache-controlmax-age=120
strict-transport-securitymax-age=31536000; includeSubDomains
x-locationEU
varyCookie, Accept-Encoding
x-varnish209497833 207478037
age11
via1.1 varnish (Varnish/7.1)
cf-cache-statusDYNAMIC
set-cookie283 Caracteres
servercloudflare
cf-ray9453fa5ebe686ee7-CDG
content-encodingbr
alt-svch3=":443"; ma=86400
statuscode200
http_versionHTTP/2

Factores externos

Wikipedia enlaza esta página en sus fuentes.
Esta página recibe enlaces de calidad de otros sitios web.
Esta página recibe backlinks de 213 dominios de referencia.
Esta página recibe un total de 49.401 backlinks.
Esta página recibe backlinks de 187 direcciones IP distintas.

Robots.txt

#
#                ..;coxkOOOOOOkxoc;'.
#             .:d0NWMMMMMMMMMMMMMMWN0xc'
#          .:kXMMMMMMMMMMMMMMMMMMMMMMMXl.
#        .c0WMMMMMMMMMMMMMMMMMMMMMMMXd'
#       ,OWMMMMMMMMMMMMMMMMMMMMMMMXo'       ..
#      cXMMMMMMXo::::::::::::::col.       .lKXl.
#     lNMMMMMMM0'                       .lKWMMNo
#    :XMMMMMMMM0'                     .l0WMMMMMNc
#   .OMMMMMMMMM0'     .ccccccc;.      ,KMMMMMMMMO.
#   :NMMMMMMMMM0'     oWMMMMMMWKc.     oWMMMMMMMN:
#   lWMMMMMMMMM0'     oWMMMMMMMMX:     ,KMMMMMMMMo
#   oMMMMMMMMMM0'     oWMMMMMMMMNc     ,KMMMMMMMMd
#   cNMMMMMMMMM0'     oWMMMMMMMNd.     lWMMMMMMMWl
#   '0MMMMMMMMWk.     ,oooooooc'      ,0MMMMMMMMK,
#    oWMMMMMMXo.                     ,0MMMMMMMMWo
#    .xWMMMXd'                     ,dXMMMMMMMMWk.
#     .xWNx'       .',''''''',,;coONMMMMMMMMMWk.
#      .:,       .l0WWWWWWWWWWWMMMMMMMMMMMMMNd.
#              .lKWMMMMMMMMMMMMMMMMMMMMMMMWk;
#            .lKWMMMMMMMMMMMMMMMMMMMMMMMNk;.
#            .ckXWMMMMMMMMMMMMMMMMMMWXkl'
#               .;ldO0XNWWWWWWNXKOxl;.
#                    ..'',,,,''..
#
#

# NOTE: Allow is a non-standard directive for robots.txt. It is allowed by Google bots. See https://developers.google.com/search/reference/robots_txt#allow

User-agent: *
# Crawl delay asks bots to wait this many seconds between requests. Ignored by google.
Crawl-delay: 5
Disallow: /admin/
Disallow: /newsletter/
Disallow: /healthcheck/
Disallow: /subpage/
Disallow: /ckeditor/
Disallow: /api/
Disallow: /static/images/
Disallow: /subscriber/
Disallow: /selfservice/
Disallow: /press-release/preview/
Disallow: /press-release/editor/

# no deep queries to search
Disallow: /search/*
Allow: /search/$

# don't index our dynamic images
Disallow: /user_media/
Disallow: /imgproxy/

# don't deep index topic pages
Disallow: /topic/?page=*

Allow: /sitemap.xml

#
# Rules for specific crawlers below. Note that these don't stack. If you create a specific user-agent rule
# you should copy the rules over from '*' above by hand.
#

# Allow Twitter to see all links
User-agent: Twitterbot
Crawl-delay: 5
Disallow:

# Allow Googlebot-News to see header images and favicons, BUT make it follow all the directives from our * group
# See below link for why we have to repeat these directives
# https://developers.google.com/search/reference/robots_txt#order-of-precedence-for-user-agents
User-agent: Googlebot-News
Disallow: /admin/
Disallow: /newsletter/
Disallow: /healthcheck/
Disallow: /subpage/
Disallow: /ckeditor/
Disallow: /api/
Disallow: /static/images/
Disallow: /subscriber/
Disallow: /selfservice/
Disallow: /press-release/preview/
Disallow: /press-release/editor/

# no deep queries to search
Disallow: /search/*
Allow: /search/$

Allow: /google_news_sitemap.xml
# Allow Google News to see header images and favicons
Allow: /user_media/
Allow: /imgproxy/
Allow: /static/images/favicons


# Googlebot-Image is now used for favicons. Allow it to see favicon-related files but nothing else
User-agent: Googlebot-Image
Disallow: /
Allow: /imgproxy/
Allow: /static/images/favicons
Allow: /favicon.ico
Allow: /white-favicon.ico
Allow: /apple-touch-icon.png
Allow: /favicon-32x32.png
Allow: /white-favicon-32x32.png
Allow: /favicon-16x16.png
Allow: /white-favicon-16x16.png
Allow: /site.webmanifest
Allow: /safari-pinned-tab.svg
Allow: /browserconfig.xml
Allow: /android-chrome-144x144.png
Allow: /mstile-150x150.png

# Don't let PetalBot crawl at all
User-agent: PetalBot
Disallow: /

# Block ChatGPT bot https://platform.openai.com/docs/gptbot
User-agent: GPTBot
Disallow: /

# Block sentione.com
User-agent: sentibot
Disallow: /

# block seoclarity.net/bot.html
User-agent: claritybot
Disallow: /

# block omgili.com/crawler.html
User-Agent: omgilibot
Disallow: /
User-Agent: omgili
Disallow: /

# All Facebook crawler user-agent to see all
User-agent: facebookexternalhit/1.1
Disallow:

User-agent: AhrefsBot
# We want this bot to crawl way slower https://ahrefs.com/robot/
Crawl-Delay: 30

Disallow: /admin/
Disallow: /newsletter/
Disallow: /healthcheck/
Disallow: /subpage/
Disallow: /ckeditor/
Disallow: /api/
Disallow: /static/images/
Disallow: /subscriber/
Disallow: /selfservice/
Disallow: /press-release/preview/
Disallow: /press-release/editor/

# no deep queries to search
Disallow: /search/*
Allow: /search/$

# don't index our dynamic images
Disallow: /user_media/
Disallow: /imgproxy/

Disallow: /topic/
Disallow: /editors/

User-agent: Amazonbot
# Restrict what Amazonbot (Alexa) can see, and a
Crawl-Delay: 10

Disallow: /admin/
Disallow: /newsletter/
Disallow: /healthcheck/
Disallow: /subpage/
Disallow: /ckeditor/
Disallow: /api/
Disallow: /static/images/
Disallow: /subscriber/
Disallow: /selfservice/
Disallow: /press-release/preview/
Disallow: /press-release/editor/

# no deep queries to search
Disallow: /search/*
Allow: /search/$

# don't index our dynamic images
Disallow: /user_media/
Disallow: /imgproxy/

Disallow: /topic/
Disallow: /editors/
Disallow: /signup/*
Allow: /signup/$

User-agent: amazon-QBusiness    # Amazon Q Web Crawler
Disallow: /

User-agent: amazon-kendra # Amazon Kendra Web Crawler
Disallow: /

Snippet (vista previa de los resultados de búsqueda)

www.biopharmadive.com
Biotech and Pharma Industry News | BioPharma Dive
BioPharma Dive provides news and analysis for biotech and biopharmaceutical executives. We cover topics like clinical trials, drug discovery and development, pharma marketing, FDA approvals and regulations, and more.

Palabras clave más importantes

Se han encontrado las siguientes palabras clave. Comprueba si esta página está bien optimizada para cada palabra clave en concreto.

Palabra claveResultadoComprobar
Pharma93%Check
biopharma92%Check
BioPharma Dive87%Check
news81%Check
Dive80%Check
Pharma Industry80%Check
Pharma Industry News80%Check
Biotech Pharma79%Check
Industry News74%Check
industry68%Check

¡Analiza ya hasta 25.000 páginas de biopharmadive.com!

Probar gratis
Garantizada la gratuidad durante la fase de prueba.

Política de cookies

Utilizamos cookies para el buen funcionamiento de nuestra web y con fines analíticos y publicitarios. Puedes activar o desactivar las cookies opcionales. Para más información consulta los siguientes enlaces.

Utilizamos estas cookies para que el sitio funcione correctamente

Con estas cookies podemos entender mejor cómo navegan las y los visitantes por nuestra web

Estas cookies nos ayudan a ofrecerte anuncios y promociones que se ajusten a tus intereses